Two-Year Results of Intravitreal Triamcinolone Acetonide Injection for the Treatment of Macular Edema Due to Central Retinal Vein Occlusion
Abstract We investigated intravitreal triamcinolone acetonide injection for the treatment of macular edema due to central retinal vein occlusion in 20 patients. Mean central macular thickness at 3 days, 1, 3, 6, 12, 18, and 24 months postoperatively was different than baseline. Visual acuity did not...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Batioglu, Figen [verfasserIn] Özmert, Emin [verfasserIn] Akmese, Elif [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2007 |
|---|
| Schlagwörter: |
|---|
| Übergeordnetes Werk: |
Enthalten in: Annals of ophthalmology - Totowa, NJ : Humana Press, 2000, 39(2007), 4 vom: 21. Sept., Seite 307-312 |
|---|---|
| Übergeordnetes Werk: |
volume:39 ; year:2007 ; number:4 ; day:21 ; month:09 ; pages:307-312 |
| Links: |
|---|
| DOI / URN: |
10.1007/s12009-007-9016-x |
|---|
| Katalog-ID: |
SPR024081647 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR024081647 | ||
| 003 | DE-627 | ||
| 005 | 20230519122243.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201006s2007 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s12009-007-9016-x |2 doi | |
| 035 | |a (DE-627)SPR024081647 | ||
| 035 | |a (SPR)s12009-007-9016-x-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q ASE |
| 100 | 1 | |a Batioglu, Figen |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Two-Year Results of Intravitreal Triamcinolone Acetonide Injection for the Treatment of Macular Edema Due to Central Retinal Vein Occlusion |
| 264 | 1 | |c 2007 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract We investigated intravitreal triamcinolone acetonide injection for the treatment of macular edema due to central retinal vein occlusion in 20 patients. Mean central macular thickness at 3 days, 1, 3, 6, 12, 18, and 24 months postoperatively was different than baseline. Visual acuity did not change. Intravitreal triamcinolone injection significantly improves short-term anatomy, but recurrences and steroid-related complications were noted in the longer term. | ||
| 650 | 4 | |a Optical Coherence Tomography |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Macular Edema |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Intravitreal Injection |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Diabetic Macular Edema |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Cystoid Macular Edema |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Özmert, Emin |e verfasserin |4 aut | |
| 700 | 1 | |a Akmese, Elif |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of ophthalmology |d Totowa, NJ : Humana Press, 2000 |g 39(2007), 4 vom: 21. Sept., Seite 307-312 |w (DE-627)486185257 |w (DE-600)2187236-3 |x 1558-9951 |7 nnns |
| 773 | 1 | 8 | |g volume:39 |g year:2007 |g number:4 |g day:21 |g month:09 |g pages:307-312 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s12009-007-9016-x |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a GBV_ILN_40 | ||
| 912 | |a GBV_ILN_63 | ||
| 912 | |a GBV_ILN_151 | ||
| 912 | |a GBV_ILN_285 | ||
| 912 | |a GBV_ILN_702 | ||
| 912 | |a GBV_ILN_2190 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4125 | ||
| 912 | |a GBV_ILN_4126 | ||
| 912 | |a GBV_ILN_4305 | ||
| 912 | |a GBV_ILN_4307 | ||
| 912 | |a GBV_ILN_4313 | ||
| 912 | |a GBV_ILN_4323 | ||
| 912 | |a GBV_ILN_4328 | ||
| 912 | |a GBV_ILN_4333 | ||
| 912 | |a GBV_ILN_4338 | ||
| 951 | |a AR | ||
| 952 | |d 39 |j 2007 |e 4 |b 21 |c 09 |h 307-312 | ||
| author_variant |
f b fb e ö eö e a ea |
|---|---|
| matchkey_str |
article:15589951:2007----::wyarslsfnrvtelracnlnaeoienetofrhtetetfauaeeau |
| hierarchy_sort_str |
2007 |
| publishDate |
2007 |
| allfields |
10.1007/s12009-007-9016-x doi (DE-627)SPR024081647 (SPR)s12009-007-9016-x-e DE-627 ger DE-627 rakwb eng 610 ASE Batioglu, Figen verfasserin aut Two-Year Results of Intravitreal Triamcinolone Acetonide Injection for the Treatment of Macular Edema Due to Central Retinal Vein Occlusion 2007 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract We investigated intravitreal triamcinolone acetonide injection for the treatment of macular edema due to central retinal vein occlusion in 20 patients. Mean central macular thickness at 3 days, 1, 3, 6, 12, 18, and 24 months postoperatively was different than baseline. Visual acuity did not change. Intravitreal triamcinolone injection significantly improves short-term anatomy, but recurrences and steroid-related complications were noted in the longer term. Optical Coherence Tomography (dpeaa)DE-He213 Macular Edema (dpeaa)DE-He213 Intravitreal Injection (dpeaa)DE-He213 Diabetic Macular Edema (dpeaa)DE-He213 Cystoid Macular Edema (dpeaa)DE-He213 Özmert, Emin verfasserin aut Akmese, Elif verfasserin aut Enthalten in Annals of ophthalmology Totowa, NJ : Humana Press, 2000 39(2007), 4 vom: 21. Sept., Seite 307-312 (DE-627)486185257 (DE-600)2187236-3 1558-9951 nnns volume:39 year:2007 number:4 day:21 month:09 pages:307-312 https://dx.doi.org/10.1007/s12009-007-9016-x lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_40 GBV_ILN_63 GBV_ILN_151 GBV_ILN_285 GBV_ILN_702 GBV_ILN_2190 GBV_ILN_4012 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4305 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4323 GBV_ILN_4328 GBV_ILN_4333 GBV_ILN_4338 AR 39 2007 4 21 09 307-312 |
| spelling |
10.1007/s12009-007-9016-x doi (DE-627)SPR024081647 (SPR)s12009-007-9016-x-e DE-627 ger DE-627 rakwb eng 610 ASE Batioglu, Figen verfasserin aut Two-Year Results of Intravitreal Triamcinolone Acetonide Injection for the Treatment of Macular Edema Due to Central Retinal Vein Occlusion 2007 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract We investigated intravitreal triamcinolone acetonide injection for the treatment of macular edema due to central retinal vein occlusion in 20 patients. Mean central macular thickness at 3 days, 1, 3, 6, 12, 18, and 24 months postoperatively was different than baseline. Visual acuity did not change. Intravitreal triamcinolone injection significantly improves short-term anatomy, but recurrences and steroid-related complications were noted in the longer term. Optical Coherence Tomography (dpeaa)DE-He213 Macular Edema (dpeaa)DE-He213 Intravitreal Injection (dpeaa)DE-He213 Diabetic Macular Edema (dpeaa)DE-He213 Cystoid Macular Edema (dpeaa)DE-He213 Özmert, Emin verfasserin aut Akmese, Elif verfasserin aut Enthalten in Annals of ophthalmology Totowa, NJ : Humana Press, 2000 39(2007), 4 vom: 21. Sept., Seite 307-312 (DE-627)486185257 (DE-600)2187236-3 1558-9951 nnns volume:39 year:2007 number:4 day:21 month:09 pages:307-312 https://dx.doi.org/10.1007/s12009-007-9016-x lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_40 GBV_ILN_63 GBV_ILN_151 GBV_ILN_285 GBV_ILN_702 GBV_ILN_2190 GBV_ILN_4012 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4305 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4323 GBV_ILN_4328 GBV_ILN_4333 GBV_ILN_4338 AR 39 2007 4 21 09 307-312 |
| allfields_unstemmed |
10.1007/s12009-007-9016-x doi (DE-627)SPR024081647 (SPR)s12009-007-9016-x-e DE-627 ger DE-627 rakwb eng 610 ASE Batioglu, Figen verfasserin aut Two-Year Results of Intravitreal Triamcinolone Acetonide Injection for the Treatment of Macular Edema Due to Central Retinal Vein Occlusion 2007 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract We investigated intravitreal triamcinolone acetonide injection for the treatment of macular edema due to central retinal vein occlusion in 20 patients. Mean central macular thickness at 3 days, 1, 3, 6, 12, 18, and 24 months postoperatively was different than baseline. Visual acuity did not change. Intravitreal triamcinolone injection significantly improves short-term anatomy, but recurrences and steroid-related complications were noted in the longer term. Optical Coherence Tomography (dpeaa)DE-He213 Macular Edema (dpeaa)DE-He213 Intravitreal Injection (dpeaa)DE-He213 Diabetic Macular Edema (dpeaa)DE-He213 Cystoid Macular Edema (dpeaa)DE-He213 Özmert, Emin verfasserin aut Akmese, Elif verfasserin aut Enthalten in Annals of ophthalmology Totowa, NJ : Humana Press, 2000 39(2007), 4 vom: 21. Sept., Seite 307-312 (DE-627)486185257 (DE-600)2187236-3 1558-9951 nnns volume:39 year:2007 number:4 day:21 month:09 pages:307-312 https://dx.doi.org/10.1007/s12009-007-9016-x lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_40 GBV_ILN_63 GBV_ILN_151 GBV_ILN_285 GBV_ILN_702 GBV_ILN_2190 GBV_ILN_4012 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4305 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4323 GBV_ILN_4328 GBV_ILN_4333 GBV_ILN_4338 AR 39 2007 4 21 09 307-312 |
| allfieldsGer |
10.1007/s12009-007-9016-x doi (DE-627)SPR024081647 (SPR)s12009-007-9016-x-e DE-627 ger DE-627 rakwb eng 610 ASE Batioglu, Figen verfasserin aut Two-Year Results of Intravitreal Triamcinolone Acetonide Injection for the Treatment of Macular Edema Due to Central Retinal Vein Occlusion 2007 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract We investigated intravitreal triamcinolone acetonide injection for the treatment of macular edema due to central retinal vein occlusion in 20 patients. Mean central macular thickness at 3 days, 1, 3, 6, 12, 18, and 24 months postoperatively was different than baseline. Visual acuity did not change. Intravitreal triamcinolone injection significantly improves short-term anatomy, but recurrences and steroid-related complications were noted in the longer term. Optical Coherence Tomography (dpeaa)DE-He213 Macular Edema (dpeaa)DE-He213 Intravitreal Injection (dpeaa)DE-He213 Diabetic Macular Edema (dpeaa)DE-He213 Cystoid Macular Edema (dpeaa)DE-He213 Özmert, Emin verfasserin aut Akmese, Elif verfasserin aut Enthalten in Annals of ophthalmology Totowa, NJ : Humana Press, 2000 39(2007), 4 vom: 21. Sept., Seite 307-312 (DE-627)486185257 (DE-600)2187236-3 1558-9951 nnns volume:39 year:2007 number:4 day:21 month:09 pages:307-312 https://dx.doi.org/10.1007/s12009-007-9016-x lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_40 GBV_ILN_63 GBV_ILN_151 GBV_ILN_285 GBV_ILN_702 GBV_ILN_2190 GBV_ILN_4012 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4305 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4323 GBV_ILN_4328 GBV_ILN_4333 GBV_ILN_4338 AR 39 2007 4 21 09 307-312 |
| allfieldsSound |
10.1007/s12009-007-9016-x doi (DE-627)SPR024081647 (SPR)s12009-007-9016-x-e DE-627 ger DE-627 rakwb eng 610 ASE Batioglu, Figen verfasserin aut Two-Year Results of Intravitreal Triamcinolone Acetonide Injection for the Treatment of Macular Edema Due to Central Retinal Vein Occlusion 2007 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract We investigated intravitreal triamcinolone acetonide injection for the treatment of macular edema due to central retinal vein occlusion in 20 patients. Mean central macular thickness at 3 days, 1, 3, 6, 12, 18, and 24 months postoperatively was different than baseline. Visual acuity did not change. Intravitreal triamcinolone injection significantly improves short-term anatomy, but recurrences and steroid-related complications were noted in the longer term. Optical Coherence Tomography (dpeaa)DE-He213 Macular Edema (dpeaa)DE-He213 Intravitreal Injection (dpeaa)DE-He213 Diabetic Macular Edema (dpeaa)DE-He213 Cystoid Macular Edema (dpeaa)DE-He213 Özmert, Emin verfasserin aut Akmese, Elif verfasserin aut Enthalten in Annals of ophthalmology Totowa, NJ : Humana Press, 2000 39(2007), 4 vom: 21. Sept., Seite 307-312 (DE-627)486185257 (DE-600)2187236-3 1558-9951 nnns volume:39 year:2007 number:4 day:21 month:09 pages:307-312 https://dx.doi.org/10.1007/s12009-007-9016-x lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_40 GBV_ILN_63 GBV_ILN_151 GBV_ILN_285 GBV_ILN_702 GBV_ILN_2190 GBV_ILN_4012 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4305 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4323 GBV_ILN_4328 GBV_ILN_4333 GBV_ILN_4338 AR 39 2007 4 21 09 307-312 |
| language |
English |
| source |
Enthalten in Annals of ophthalmology 39(2007), 4 vom: 21. Sept., Seite 307-312 volume:39 year:2007 number:4 day:21 month:09 pages:307-312 |
| sourceStr |
Enthalten in Annals of ophthalmology 39(2007), 4 vom: 21. Sept., Seite 307-312 volume:39 year:2007 number:4 day:21 month:09 pages:307-312 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Optical Coherence Tomography Macular Edema Intravitreal Injection Diabetic Macular Edema Cystoid Macular Edema |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Annals of ophthalmology |
| authorswithroles_txt_mv |
Batioglu, Figen @@aut@@ Özmert, Emin @@aut@@ Akmese, Elif @@aut@@ |
| publishDateDaySort_date |
2007-09-21T00:00:00Z |
| hierarchy_top_id |
486185257 |
| dewey-sort |
3610 |
| id |
SPR024081647 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR024081647</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519122243.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201006s2007 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s12009-007-9016-x</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR024081647</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s12009-007-9016-x-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">ASE</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Batioglu, Figen</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Two-Year Results of Intravitreal Triamcinolone Acetonide Injection for the Treatment of Macular Edema Due to Central Retinal Vein Occlusion</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2007</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract We investigated intravitreal triamcinolone acetonide injection for the treatment of macular edema due to central retinal vein occlusion in 20 patients. Mean central macular thickness at 3 days, 1, 3, 6, 12, 18, and 24 months postoperatively was different than baseline. Visual acuity did not change. Intravitreal triamcinolone injection significantly improves short-term anatomy, but recurrences and steroid-related complications were noted in the longer term.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Optical Coherence Tomography</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Macular Edema</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Intravitreal Injection</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Diabetic Macular Edema</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cystoid Macular Edema</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Özmert, Emin</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Akmese, Elif</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Annals of ophthalmology</subfield><subfield code="d">Totowa, NJ : Humana Press, 2000</subfield><subfield code="g">39(2007), 4 vom: 21. Sept., Seite 307-312</subfield><subfield code="w">(DE-627)486185257</subfield><subfield code="w">(DE-600)2187236-3</subfield><subfield code="x">1558-9951</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:39</subfield><subfield code="g">year:2007</subfield><subfield code="g">number:4</subfield><subfield code="g">day:21</subfield><subfield code="g">month:09</subfield><subfield code="g">pages:307-312</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s12009-007-9016-x</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_702</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2190</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4328</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4333</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">39</subfield><subfield code="j">2007</subfield><subfield code="e">4</subfield><subfield code="b">21</subfield><subfield code="c">09</subfield><subfield code="h">307-312</subfield></datafield></record></collection>
|
| author |
Batioglu, Figen |
| spellingShingle |
Batioglu, Figen ddc 610 misc Optical Coherence Tomography misc Macular Edema misc Intravitreal Injection misc Diabetic Macular Edema misc Cystoid Macular Edema Two-Year Results of Intravitreal Triamcinolone Acetonide Injection for the Treatment of Macular Edema Due to Central Retinal Vein Occlusion |
| authorStr |
Batioglu, Figen |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)486185257 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut aut aut |
| collection |
springer |
| remote_str |
true |
| illustrated |
Not Illustrated |
| issn |
1558-9951 |
| topic_title |
610 ASE Two-Year Results of Intravitreal Triamcinolone Acetonide Injection for the Treatment of Macular Edema Due to Central Retinal Vein Occlusion Optical Coherence Tomography (dpeaa)DE-He213 Macular Edema (dpeaa)DE-He213 Intravitreal Injection (dpeaa)DE-He213 Diabetic Macular Edema (dpeaa)DE-He213 Cystoid Macular Edema (dpeaa)DE-He213 |
| topic |
ddc 610 misc Optical Coherence Tomography misc Macular Edema misc Intravitreal Injection misc Diabetic Macular Edema misc Cystoid Macular Edema |
| topic_unstemmed |
ddc 610 misc Optical Coherence Tomography misc Macular Edema misc Intravitreal Injection misc Diabetic Macular Edema misc Cystoid Macular Edema |
| topic_browse |
ddc 610 misc Optical Coherence Tomography misc Macular Edema misc Intravitreal Injection misc Diabetic Macular Edema misc Cystoid Macular Edema |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
Annals of ophthalmology |
| hierarchy_parent_id |
486185257 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Annals of ophthalmology |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)486185257 (DE-600)2187236-3 |
| title |
Two-Year Results of Intravitreal Triamcinolone Acetonide Injection for the Treatment of Macular Edema Due to Central Retinal Vein Occlusion |
| ctrlnum |
(DE-627)SPR024081647 (SPR)s12009-007-9016-x-e |
| title_full |
Two-Year Results of Intravitreal Triamcinolone Acetonide Injection for the Treatment of Macular Edema Due to Central Retinal Vein Occlusion |
| author_sort |
Batioglu, Figen |
| journal |
Annals of ophthalmology |
| journalStr |
Annals of ophthalmology |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2007 |
| contenttype_str_mv |
txt |
| container_start_page |
307 |
| author_browse |
Batioglu, Figen Özmert, Emin Akmese, Elif |
| container_volume |
39 |
| class |
610 ASE |
| format_se |
Elektronische Aufsätze |
| author-letter |
Batioglu, Figen |
| doi_str_mv |
10.1007/s12009-007-9016-x |
| dewey-full |
610 |
| author2-role |
verfasserin |
| title_sort |
two-year results of intravitreal triamcinolone acetonide injection for the treatment of macular edema due to central retinal vein occlusion |
| title_auth |
Two-Year Results of Intravitreal Triamcinolone Acetonide Injection for the Treatment of Macular Edema Due to Central Retinal Vein Occlusion |
| abstract |
Abstract We investigated intravitreal triamcinolone acetonide injection for the treatment of macular edema due to central retinal vein occlusion in 20 patients. Mean central macular thickness at 3 days, 1, 3, 6, 12, 18, and 24 months postoperatively was different than baseline. Visual acuity did not change. Intravitreal triamcinolone injection significantly improves short-term anatomy, but recurrences and steroid-related complications were noted in the longer term. |
| abstractGer |
Abstract We investigated intravitreal triamcinolone acetonide injection for the treatment of macular edema due to central retinal vein occlusion in 20 patients. Mean central macular thickness at 3 days, 1, 3, 6, 12, 18, and 24 months postoperatively was different than baseline. Visual acuity did not change. Intravitreal triamcinolone injection significantly improves short-term anatomy, but recurrences and steroid-related complications were noted in the longer term. |
| abstract_unstemmed |
Abstract We investigated intravitreal triamcinolone acetonide injection for the treatment of macular edema due to central retinal vein occlusion in 20 patients. Mean central macular thickness at 3 days, 1, 3, 6, 12, 18, and 24 months postoperatively was different than baseline. Visual acuity did not change. Intravitreal triamcinolone injection significantly improves short-term anatomy, but recurrences and steroid-related complications were noted in the longer term. |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_40 GBV_ILN_63 GBV_ILN_151 GBV_ILN_285 GBV_ILN_702 GBV_ILN_2190 GBV_ILN_4012 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4305 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4323 GBV_ILN_4328 GBV_ILN_4333 GBV_ILN_4338 |
| container_issue |
4 |
| title_short |
Two-Year Results of Intravitreal Triamcinolone Acetonide Injection for the Treatment of Macular Edema Due to Central Retinal Vein Occlusion |
| url |
https://dx.doi.org/10.1007/s12009-007-9016-x |
| remote_bool |
true |
| author2 |
Özmert, Emin Akmese, Elif |
| author2Str |
Özmert, Emin Akmese, Elif |
| ppnlink |
486185257 |
| mediatype_str_mv |
c |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| doi_str |
10.1007/s12009-007-9016-x |
| up_date |
2024-07-03T23:21:39.932Z |
| _version_ |
1803601995296145408 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR024081647</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519122243.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201006s2007 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s12009-007-9016-x</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR024081647</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s12009-007-9016-x-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">ASE</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Batioglu, Figen</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Two-Year Results of Intravitreal Triamcinolone Acetonide Injection for the Treatment of Macular Edema Due to Central Retinal Vein Occlusion</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2007</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract We investigated intravitreal triamcinolone acetonide injection for the treatment of macular edema due to central retinal vein occlusion in 20 patients. Mean central macular thickness at 3 days, 1, 3, 6, 12, 18, and 24 months postoperatively was different than baseline. Visual acuity did not change. Intravitreal triamcinolone injection significantly improves short-term anatomy, but recurrences and steroid-related complications were noted in the longer term.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Optical Coherence Tomography</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Macular Edema</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Intravitreal Injection</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Diabetic Macular Edema</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cystoid Macular Edema</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Özmert, Emin</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Akmese, Elif</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Annals of ophthalmology</subfield><subfield code="d">Totowa, NJ : Humana Press, 2000</subfield><subfield code="g">39(2007), 4 vom: 21. Sept., Seite 307-312</subfield><subfield code="w">(DE-627)486185257</subfield><subfield code="w">(DE-600)2187236-3</subfield><subfield code="x">1558-9951</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:39</subfield><subfield code="g">year:2007</subfield><subfield code="g">number:4</subfield><subfield code="g">day:21</subfield><subfield code="g">month:09</subfield><subfield code="g">pages:307-312</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s12009-007-9016-x</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_702</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2190</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4328</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4333</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">39</subfield><subfield code="j">2007</subfield><subfield code="e">4</subfield><subfield code="b">21</subfield><subfield code="c">09</subfield><subfield code="h">307-312</subfield></datafield></record></collection>
|
| score |
7.3979177 |